Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)
Not Applicable
- Conditions
- Patients with unresectable or metastatic colon cancer registant to fluorouracil treatment
- Registration Number
- JPRN-UMIN000000841
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
"1) Cavity fluid which needs drainage 2) with active double cancer except ca. in situ 3) with peripheral nerve disorder 4) with infectious disease which needs treatment 5) under watery diarrhea 6) with mental disorder which disturbs registration to this study 7) patients who receive steroids treatment 8) Cardiac failure, liver dysfunction, or renal dysfunction which disturb Registration to this study 9) pregnant women or women who like to be pregnant 10) history of severe allergy against drug 11) doctor's dicision not to be registered to this study"
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate(RECIST), Duration of response
- Secondary Outcome Measures
Name Time Method Overall Survival, Feasibility Adverse Events